Valda datamodeller

Du måste vara inloggad för att välja flera datamodeller, ladda ner dem eller analysera dem.

71 Sökresultat.
Relevans Bedömning Nya först Gamla först

Eligibility Carcinoma, Non-small-cell Lung NCT00654420

- 2017-11-14 - 1 Formulär, 2 Item-grupper, 18 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
A Study Evaluating Dalotuzumab (MK0646) in Combination With Erlotinib for Patients With Non-Small Cell Lung Cancer (0646-007); ODM derived from: https://clinicaltrials.gov/show/NCT00654420

Eligibility Carcinoma, Non-Small-Cell Lung NCT00637624

- 2017-11-14 - 1 Formulär, 2 Item-grupper, 11 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
N-AcetylCysteine vs. Placebo to Prevent Neurotoxicity Induced by Platinum Containing Chemotherapy; ODM derived from: https://clinicaltrials.gov/show/NCT00637624

Eligibility Carcinoma, Non-Small-Cell Lung NCT00625352

- 2017-11-14 - 1 Formulär, 2 Item-grupper, 14 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Study of Developing an Optimal Gemcitabine Based Regimen to Treat Elderly Patients With Advanced Non-Small Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00625352

Eligibility Carcinoma, Non-Small-Cell Lung NCT00432640

- 2017-11-14 - 1 Formulär, 2 Item-grupper, 12 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Assessment of Surgical sTaging vs Endoscopic Ultrasound in Lung Cancer: a Randomized Clinical Trial (ASTER Study); ODM derived from: https://clinicaltrials.gov/show/NCT00432640

Eligibility Carcinoma, Non-Small-Cell Lung NCT00425022

- 2017-11-13 - 1 Formulär, 2 Item-grupper, 20 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
VATS Lobectomy for Clinical Stage IB or II Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00425022

Eligibility Cancer NCT00708448

- 2017-11-09 - 1 Formulär, 2 Item-grupper, 14 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Early Prediction of Therapeutic Response to Targeted Therapy in Stage IIIB/IV or Recurrent Lung Cancer Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00708448

Eligibility Cancer NCT00630110

- 2017-11-09 - 1 Formulär, 2 Item-grupper, 16 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Phase 1/2 Study of Vascular Disrupting Agent NPI-2358 + Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00630110

Eligibility Non-small Cell Lung Cancer NCT00569114

- 2017-08-16 - 1 Formulär, 1 Item-grupp, 12 Dataelement, 1 Språk
Item-grupp: Criteria
Phase 1 Study of TG01 and Erlotinib in Non-small Cell Lung Cancer (NCSLC) Patients; ODM derived from: https://clinicaltrials.gov/show/NCT00569114

Eligibility Non-Small-Cell Lung Cancer NCT01037998

- 2017-05-22 - 1 Formulär, 2 Item-grupper, 13 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01037998

Eligibility Lung Neoplasms NCT00090701

- 2016-10-11 - 1 Formulär, 2 Item-grupper, 20 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
A Phase 2, Open-Label, Multicenter Study of the GARFT Inhibitor in Patients With Metastatic Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00090701

Eligibility Non-Small-Cell Lung Carcinoma NCT00310232

- 2016-07-31 - 1 Formulär, 2 Item-grupper, 22 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Epoetin Alfa in Advanced Non-Small Cell Lung Cancer (EPO-CAN-20); ODM derived from: https://clinicaltrials.gov/show/NCT00310232

Eligibility Carcinoma, Non-Small-Cell Lung NCT00088556

- 2016-07-22 - 1 Formulär, 2 Item-grupper, 11 Dataelement, 1 Språk
Item-grupper: Inclusion Criteria, Exclusion Criteria
Carboplatin, Paclitaxel and TLK286 (Telcyta) as First-Line Therapy in Advanced Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00088556

Kontakt

Använd detta formulär för feedback, frågor och förslag på förbättringar.

Fält markerade med * är obligatoriska.

Hjälp

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial